SCHEMBL7714566

SCHEMBL7714566

Nc1ncc(Oc2cc(F)cc(F)c2)c(N2CCN(CCO)CC2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 3/20 0.41
ROCK1 Q13464 3/20 0.41
HTR3E A5X5Y0 2/20 0.39
HTR3B O95264 2/20 0.39
HTR3A P46098 2/20 0.39
HTR3D Q70Z44 2/20 0.39
HTR3C Q8WXA8 2/20 0.39
HRH4 Q9H3N8 1/20 0.38
SCN9A Q15858 1/20 0.36
PIK3CG P48736 1/20 0.36
STAT6 P42226 1/20 0.36
MAP4K4 O95819 1/20 0.36
TSHR P16473 2/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HTT P42858 2/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HRH1 P35367 1/20 0.34
HTR1A P08908 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714357 0.89 HTR3E (0.43) ROCK2ROCK1HTR3EHTR3BHTR3A
SCHEMBL7714141 0.89 SCN9A (0.47) ROCK2ROCK1HTR3EHTR3BHTR3A
SCHEMBL7713453 0.84 HTR3E (0.44) ROCK2ROCK1HTR3EHTR3BHTR3A
SCHEMBL7708442 0.82 LMNA (0.45) ROCK2ROCK1HRH4TSHRHSD17B10
SCHEMBL7714186 0.82 KMT2A (0.48) ROCK2ROCK1HRH4TSHRHSD17B10
SCHEMBL7714588 0.82 HTT (0.44) ROCK2ROCK1HRH4HTTALDH1A1
SCHEMBL7714556 0.82 KMT2A (0.44) ROCK2ROCK1HRH4HTTKDM4E
SCHEMBL7716686 0.82 HTR3E (0.42) ROCK2ROCK1HTR3EHTR3BHTR3A
SCHEMBL7714256 0.82 ROCK2 (0.43) ROCK2ROCK1SCN9AHTR1A
SCHEMBL7714027 0.82 CHRNA7 (0.43) ROCK2ROCK1HRH4SCN9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed